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Female sexual maturation requires erythroblastosis B (erbB)4 signaling in hypothalamic astro-
cytes; however, the mechanisms by which erbB4 contributes to this process are incompletely
understood. Here we show that SynCAM1, a synaptic adhesion molecule with signaling capa-
bilities, is not only expressed highly in neurons, but also in hypothalamic astrocytes and is
functionally associated with erbB4 receptor activity. Whereas SynCAM1 expression is dimin-
ished in astrocytes with impaired erbB4 signaling, ligand-dependent activation of astroglial
erbB4 receptors results in rapid association of erbB4 with SynCAM1 and activation of SynCAM1
gene transcription. To determine whether astrocytic SynCAM1-dependent intracellular sig-
naling is required for normal female reproductive function, we generated transgenic mice that
express in an astrocyte-specific manner a dominant-negative form of SynCAM1 lacking the
intracellular domain. Themutant protein was correctly targeted to the cell membrane andwas
functionally viable as shown by its ability to block intracellular calcium/calmodulin-dependent
serine protein kinase redistribution, a major SynCAM1-mediated event. Dominant-negative-
SynCAM1 female mice had a delayed onset of puberty, disrupted estrous cyclicity, and reduced
fecundity. These deficits were associated with a reduced capacity of neuregulin-dependent
erbB4 receptor activation to elicit prostaglandin E2 release from astrocytes and GnRH release
from the hypothalamus. We conclude that one of the mechanisms underlying erbB4 receptor-
mediated facilitation of glial-neuronal interactions in the neuroendocrine brain involves Syn-
CAM1-dependent signaling and that this interaction is required for normal female reproduc-
tive function. (Endocrinology 152: 2364–2376, 2011)
The erythroblastosis (erbB) family of tyrosine kinasereceptors and their respective ligands regulate a variety
of developmental processes and mature cellular functions
in different tissues (1). In the nervous system, erbB recep-
tors not only contribute to the control of neurogenesis and
transsynaptic communication but also play a central role
in the regulation of glial biology and development (2, 3).
In the case of astrocytes, it was recently shown that neu-
regulin (NRG)-1-dependent activation of erbB receptors
regulates the timing of astrogenesis in brain (4). Yet little
is knownabout the contributionofNRG-erbB signaling to
other aspects of astrocyte biology.
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An area inwhichwe are beginning to better understand
the mechanisms by whichNRG1-erbB signaling regulates
neuron-astrocyte interactions is themammalianhypothal-
amus. Hypothalamic astrocytes express erbB2 and erbB4
receptors but are devoid of erbB3 receptors (5). Ligand-
dependent activationof anastroglial erbB4/2 complex sets
inmotion a signaling cascade that results in prostaglandin
E2 (PGE2) production (5). PGE2 then stimulates secretion
of GnRH, the neuropeptide controlling sexual develop-
ment, from hypothalamic neurons (6). In mice expressing
a dominant-negative (DN) erbB4 receptor in hypothalamic
astrocytes [glial fibrillary acidic protein (GFAP)-DNerbB4]
these events are inhibited,withGFAP-DNerbB4 femalemice
havingdelayed sexualmaturationanddiminished reproduc-
tive capacity (7). These deficiencies are associated with re-
duced PGE2 formation and impaired capacity of themutant
astrocytes to elicit GnRH release in response to NRG1
stimulation.
To identify the gene products affected by this astrocytic-
specific disruption in erbB signaling we used isotope-coded
affinity tags (ICAT) (8), a proteomics approach that identi-
fies and quantifies individual components of highly hetero-
geneous protein mixtures (9, 10), such as those found in the
nervous system. By comparing the hypothalamic proteome
of wild-type (WT) mice to GFAP-DNerbB4 mice, we iden-
tified synaptic cell adhesion molecule 1 [SynCAM1; also
named tumor suppressor of lung cancer-1 (Tslc1); and
Nectin-like protein 2], a synaptic adhesion molecule with
signaling capabilities encoded by the CADM1 gene (11),
as a protein affected by the loss of astrocytic erbB4 func-
tion. In the companion paper,we establish that SynCAM1
is a mediator of adhesion between hypothalamic astro-
cytes and GnRH neurons (12). Here we show that Syn-
CAM1 is expressed in hypothalamic astrocytes and this
expression is regulated by erbB4 signaling. Our results
show that SynCAM1, as a signaling molecule, uses its in-
tracellular domain tomediate erbB4-dependent activation
of astrocyte-to-GnRH neuron communication, thereby





in accordance with National Institutes of Health guidelines for
the Care and Use of Laboratory Animals. All experimental pro-
tocols were approved by the Animal Care and Use Committee of
the Oregon National Primate Research Center.
ICAT labeling
A region rostral to the hypothalamus containing the diag-
onal band of Broca and preoptic area (for simplicity referred
to as the POA) was dissected from four GFAP-DNerbB4 and
four WT FvB immature (d 28) female mice and rapidly frozen
on dry ice. The tissue was then transported to the Institute for
Systems Biology in Seattle, WA, in which the proteins were
extracted with mammalian protein extraction reagent follow-
ing the manufacturer’s protocol (Pierce, Rockford, IL). The
samples were spun to pellet-insoluble material and then dried
down to 100 l. The protein content of each sample was
determined with the Pierce BCA reagent. Four hundred mi-
croliters of labeling buffer (0.05% sodium dodecyl sulfate;
200 mM Tris, pH 8.3; 5 mM EDTA; 6 M urea) were added to
each sample. The proteinswere reducedwith 5mMTris, 2-car-
boxyethylphosphine. Then 535 nmol of the ICAT reagent
were added to each sample (9). Proteins from the POA of WT
mice were labeled with the light ICAT reagent, and the pro-
teins from the POAofGFAP-DNerbB4micewere labeledwith
the heavy ICAT form. Because this form contains eight deu-
teriums, it is 8 Da heavier than the light reagent that contains
no deuterium (8). The labeling reaction was incubated for 90
min at room temperature. An aliquot of each sample was run
on a SDS-PAGE gel to check for labeling, indicated by a small
shift in the size of the Coomassie-stained protein bands. The
ICAT reaction was then quenched with an excess of dithio-
threitol (13), and the proteins were digested overnight at 37 C
with trypsin (1:50, wt/wt). Complete digestion was verified
via SDS-PAGE and Coomassie staining. The resultant pep-
tides were subjected to separation on a strong-ion exchange
column and ICAT-bound peptides were isolated using an avi-
din-affinity column (8, 13). These purified peptides were ly-
ophilized and processed as described below.
Mass spectrometry
Peptide mixtures were analyzed by electrospray ionization
tandem mass spectrometry coupled to capillary liquid chroma-
tography (LC-MS/MS) (8, 9). The procedure was performed in
the proteomics core facility at the Institute for Systems Biology,
and the data gathered were retrieved on-line. The lyophilized
peptideswere solubilized in50l of anaqueous solutionof0.4%
acetic acid and 0.005% heptafluorobutyric acid. Approxi-
mately 2 l of this solution was pressure bomb loaded onto a
75 m inner diameter reverse-phase capillary column packed
with 10 cm of Magic C18 resin (Michrom Bioresources, Au-
burn, CA). The peptides were subsequently eluted off the col-
umn using a linear solvent gradient of increasing acetonitrile
concentration and ionized using electrospray ionization with
a liquid chromatography set-up, as described (14). The ion-
ized liquid chromatography stream was analyzed by tandem
mass spectrometry on a LCQ-Classic (Thermofinnigan, San
Jose, CA).
Using this LC-MS/MS system, the ICAT-labeled peptide
pairs coeluting from the C18 column were automatically quan-
tified by measuring their ratios before they entered the mass
spectrometer. Alternative scans were also automatically selected
for mass spectrometry fragmentation via collision-induced dis-
sociation (CID). Amino acid sequence assignments were then
generated from the CID analysis by searching the mass spec-
trometer data files against a mouse peptide/protein database us-
ing the SEQUEST algorithm (15). The SEQUEST-generated lists
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were processed for easier user analysis using the INTERACT
interface (16). Once this information was obtained, single ion
chromatograms were reconstructed for each peptide pair using
XPRESS software (13).
Plasmid constructs
For promoter assays, we used a DNA fragment containing
1.9 kb from the 5 flanking region of the human SynCAM1
gene (NM_014333). The DNA fragment was isolated by PCR
and cloned into the pGL3 vector (Promega, Madison, WI).
The fragment extends to 50 bp upstream from the ATG trans-
lation initiation site in exon 1. The sense and antisense primers
used for amplification are listed in Table 1; the primer positions
are relative to the human chromosome 11 genomic contig
(NT_033899). ErbB4 receptorswere expressed using expression
plasmids encoding either the full-length human erbB4 (herbB4)
(17), or a mutated form of erbB4 (DNerbB4), lacking the intra-
cellular domain of the receptor (7). To generate aDNSynCAM1
expression plasmid we used a 1.2-kb DNA fragment extending
from the transcription start site through the transmembrane do-
main of mouse SynCAM1 (mSynCAM1). The latter includes the
cell membrane targeting domain of the mSynCAM1 isoform 4
gene (NM_018770). The DNA fragment was isolated by PCR
from an expression plasmid that contains the complete coding
sequence of mSynCAM1 (18) and using primers listed in Table
1. The amplified product was directional cloned using BglII and
SalI into pEGFP-N1 (Promega) and is referred to as pEGFP-N1
DN SynCAM1. To generate the construct that targets DN Syn-
CAM1 toastrocyteswedigestedpEGFP-N1DNSynCAM1with
EcoRI andNotI and blunt-ligated the fragment into the pGfa2-
Lac1 backbone (19), thus placing DN SynCAM1 under control
of the human GFAP promoter. This plasmid is referred to as
pGFAP DN SynCAM1. To generate the calcium/calmodulin-
dependent serine protein kinase (CASK) expression plasmid,
we used a DNA fragment that encodes the complete coding
sequence of the ratCASK gene (NM_022184). The DNA frag-
ment used was isolated by PCR from a pEGFP-CASK expres-
sion plasmid (generously donated by Dr. Thomas Su¨dhof,
Stanford University, School of Medicine, Palo Alto, CA), us-
ing primers listed in Table 1. TheCASKPCRproduct was then
directional cloned using SalI and SacII into pDsRed2-N1
(Promega).
Yeast two-hybrid assay
Two-hybrid assays were performed using the yeast strain
EGY48 harboring LacZ and LEU2 reporters, as described (20).
The erbB4 intracellular domain (amino acid residues 676-1308)
(21) was generated by PCR, subcloned into NotI/EagI sites of
pEG202, and used as bait. The intracellular domain of Syn-
CAM1 (18) and PSD-95 PDZ domains 1 and 2 (a gift from Dan
Pak andMorgan Sheng,Massachusetts Institute of Technology,
Boston, MA) were subcloned into the EcoRI/XhoI site of
pJG4–5.Oligonucleotide-directedPCRmutagenesiswasused to
create themutant (K751M)kinase-dead erbB4 receptor.All con-
structs were verified by DNA sequencing.
DN SynCAM1 transgenic mice
After removing theDNSynCAM1 construct from the pGfa2-
Lac1 backbone by digestion with EcoR1, the GFAP DN Syn-
CAM1 transgene was injected into the pronucleus of FvB/N1
zygotes. DN SynCAM1 positive offspring were identified by
PCR genotyping with primers that specifically amplify a region
spanning the junction between the SynCAM1 and enhanced
green fluorescence protein (EGFP) coding regions of the trans-
gene (Table 1). The following PCR conditions were used for
genotyping: an initial activation step of 5 min at 95 C, followed
by 39 cycles of denaturing at 95 C for 30 sec, annealing at 55 C
for 30 sec, and extension at 72 C for 1min, and a final extension
at 72 C for 10 min. The samples were loaded onto a 2% agarose
gel and the PCR products were visualized by ethidium bromide
staining.
The tissue distribution of the DN SynCAM1 protein in trans-
genicmicewas characterizedbyWesternblotting, and its cellular
distribution in brain by immunohistofluorescence. To determine
the effect of the DN SynCAM1 transgene on reproductive biol-
ogy, we conducted several experiments. Litters consisting ofWT
and heterozygous DN SynCAM1mice from both line (L) 27 and
L45wereweaned on d 18, and the femaleswere placed in groups
of fiveper cage. Startingond21, the animalswere inspecteddaily
for vaginal opening. The time of first ovulation was functionally
confirmed by mating WT and DN SynCAM1 females at the age
of vaginal opening with WT males and determining the time
interval between mating and delivery of a litter for each group.
The day ofmatingwas determined by confirming the presence of
a copulatory plug in themouse’s vagina; this daywas considered
as d0of pregnancy.When litterswere born, the date andnumber
of pups were recorded. Average litter size, interval between vag-
inal opening and first ovulation, and interval between vaginal
opening and birth of the first litter were calculated. The females
were bred for two consecutive litters, and L45 females were sub-
sequently used for assessment of estrous cyclicity. To perform
this experiment, the animals were left undisturbed after weaning
TABLE 1. Primers used for conventional PCR and real-time PCR
Conventional PCR primers
Gene name Accession no. Sense primer Position Antisense primer Position
SynCAM1 promoter NT_033899 tatttttattagagacggagtttc 18,939,510-487 gcggacagctaatgagatg 18,937,656-578
DN SynCAM1 AF539424 agatctaggcgtgtacggtgggaggtcta 122–145 gtcgacgcaaaatagcggcccagaatgat 1405–1428
DN SynCAM1 genotyping AF539424 and U55762 cctcccacaacaaccaccaccact 1140–1163 gccctcgccggacacgctgaac 759–780
CASK NM_022184 tattcggtcgaccggaccatggccgacgacgacgtgct 25–50 tattcgccgcgggcaatagacccaggagaccgggac 2737–2760










SynCAM1 AF539424 ccctcctcccacaacaacc 1033-1051 ggtcccctcttcacctgctc 1107–1126 cacctccatccttaccatcatcacagattct 1075–1105
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the second litter; at 4–6 months of age, vaginal lavages were
performeddaily for3wk, and thedifferentphasesof their estrous
cycle were recorded.
Statistical analysis
Quantitative data were analyzed using SigmaStat 3.1 soft-
ware (Systat Software Inc., San Jose, CA). The data were first
subjected to anormality test andan equal variance test.Data that
passed these two testswere thenanalyzedas follows: comparison
of two groups was performed with the Student’s t test, data sets
containing more than two groups were analyzed with one-way
ANOVA followed by the Student-Newman-Keuls multiple test
for individual means. Data that failed either the normality or
equal variance test were analyzed by nonparametric methods
such as the Mann-Whitney rank sum test (two groups), the
Kruskal-Wallis one-way ANOVA on ranks followed by the Stu-
dent-Newman-Keuls method of pair-wise multiple comparison
procedure (multiple groups). The null hypothesis was rejected at
the 0.05 level for all analyses.
Supplemental material and methods
A detailed description of procedures involving cell culture,
antibodies, Western blots, immunoprecipitation assays, immu-
nohistofluorescence, RNA extraction, real-time PCR, promoter
assays, PGE2, and GnRH assays is provided as Supplementary
Material and Methods (published on The Endocrine Society’s
Journals Online web site at http://end.endojournals.org).
Results
Quantitative proteomic analysis reveals a
reduction in SynCAM1 levels in the hypothalamus
of mice with disrupted astrocytic erbB receptor
signaling
Because in rodents most GnRH neurons are located in
the POA of the hypothalamus, we collected this region
from reproductively immature 28-d-old WT and GFAP-
DNerbB4 female mice and subjected it to tandem mass
spectrometry-ICAT analysis. Themost reproducible find-
ing (five independent hits) was a decrease in the levels of
SynCAM1 in transgenics (Fig. 1, A–C).Western blot anal-
ysis of the POA using a monoclonal antibody (3E1) that
specifically recognizes SynCAM1 (22) confirmed this re-
duction (Fig. 1, D and E). Polyclonal antibodies (18, 22)
(pleio-SynCAM antibodies) that recognize the protein
products from three of the four known SynCAM genes
(SynCAM1, -2, and -3) (22) showed that the mouse hy-
pothalamus also contains SynCAM2 and -3 but that the
abundance of these proteins does not change in themutant
animals (not shown).
SynCAM1 abundance in astrocytes is regulated by
erbB4 signaling
SynCAM1, an adhesion protein expressed in neurons
(18) and some glial populations (23), has been implicated
in the formation and organization of excitatory synapses
in brain (18, 22). Because the mechanisms regulating Syn-
CAM1expression and function are not understood, itwas
intriguing that SynCAM1expression in the hypothalamus
was reduced as a consequence of disrupted astrocytic
erbB receptor signaling. Therefore, we sought to exam-
ine the possibility that alterations in SynCAM1 levels in
the hypothalamus of GFAP-DNerbB4 mice reflects, at
least in part, changes in astrocytic SynCAM1 expres-
sion. Levels of SynCAM1 protein were compared in
cultures of astrocytes purified from WT and transgenic
mice.Western blot analysis using the SynCAM1 antibody
3E1 (Fig. 2, A and B) revealed that the abundance of Syn-
CAM1 was strikingly reduced in astrocytes from GFAP-
DNerbB4 mice. Furthermore, treatment of WT hypotha-
lamic astrocytes with NRG1 (3 nM) significantly (P 
0.05) increased SynCAM1 mRNA levels (Fig. 2C) and
SynCAM1 protein levels (Fig. 2D). These results indicate
that NRG1-erbB signaling promotes SynCAM1 expres-
sion in astrocytes.
To determine whether the effects of NRG1-erbB sig-
naling on SynCAM1 expression are mediated by tran-
scriptional mechanisms, we used a luciferase reporter
assay. A 1.9-kb DNA fragment containing the 5 flank-
ing region of the human SynCAM1 gene was cloned into
a luciferase reporter plasmid. This construct was then
transfected into the astrocytic progenitor cell line BAS-
8.1 (24), which does not express erbB4 receptors (data
not shown). Treatment of BAS-8.1 cells with NRG1 (3
nM) did not change the activity of the SynCAM1 reporter
construct. However, when an erbB4-expression plasmid
was cotransfected with the luciferase reporter plasmid,
NRG1 treatment increased SynCAM1promoter activity
by 2-fold (P  0.01) (Fig. 2E). Importantly, transient ex-
pression of DNerbB4 did not affect basal SynCAM1 pro-
moter activity but obliterated the stimulatory effect of
NRG1 on cells expressing the full-length receptor (Fig.
2E). These results indicate that activation of astrocytic
erbB4 receptor contributes to maintaining glial synthesis
of SynCAM1 via transactivation of SynCAM1 gene
transcription.
Ligand-dependent activation of astrocytic erbB4
receptors results in physical association of the
receptors with SynCAM1
In addition to mediating cell adhesion via its extracel-
lular domain, SynCAM1 uses specific motifs of its intra-
cellular domain to interact with other membrane-associ-
ated proteins and initiate signal transduction (11, 18).
Considering these findings, we sought to determine
whether SynCAM1 can physically interact with erbB4 re-
ceptors. First, we compared the cellular distribution of
Endocrinology, June 2011, 152(6):2364–2376 endo.endojournals.org 2367
erbB4 and SynCAM immunoreactivity in hypothalamic
astrocytes stimulated with NRG1 (3 nM). In nonstimu-
lated cells, erbB4 immunoreactivity (red) was diffuse and
not associated with SynCAM (green, Fig. 3, A and C).
Forty minutes after NRG1 administration, erbB4 recep-
tors appear to cluster on the cell membrane, as suggested
FIG. 1. The abundance of SynCAM1 is reduced in the POA of immature mice with disrupted astrocytic erbB4 receptor signaling (GFAP-DNerbB4),
as assessed by ICAT-LC-MS/MS and Western blot. Peptides from the POA of WT and GFAP-DNerbB4 mice were labeled with the light and heavy
form of the ICAT reagent, respectively. A, A representative mass chromatogram of the sequencing of one of the SynCAM1 peptide pairs detected
using tandem mass spectrometry. The selected peptides were fragmented using CID, and the resultant C-terminus (b3, y1) and N-terminus (b1, y3)
ions are displayed. B, Reconstructed single ion chromatograms of the isotopically light (WT) and heavy (GFAP-DNerbB4) SynCAM1 peptide
partners, created by plotting the intensity of the signal observed at the relevant m/z value (light, 1138.405; heavy 1141.093) as a function of
retention time (minutes). The area under the curve fitted to the SynCAM1 peptide ions pairs was greatly reduced in the GFAP-DNerbB4 samples
compared with wild-type (WT: 5.00E07; GFAP-DNerbB4: 1.57E07). The numbers in the upper right-hand corner represent the scale of each
chromatogram. C, Heavy to light ratio of five SynCAM1 peptides sequenced from WT (light) and GFAP-DNerbB4 (heavy) samples (measured by the
area under the curve on the chromatogram using the INTERACT software package) shows erbB4-dependent SynCAM1 expression. **, P  0.02
vs. WT animals. D, Decreased SynCAM1 protein levels in the POA of 30-d-old female GFAP-DNerbB4 mice as determined by Western blot analysis
using antibody 3E1 (25 g of protein per lane). E, Densitometric analysis of the SynCAM1 signal shown in D. **, P  0.02 vs. WT animals.
Numbers in parentheses above bars represent the number of independent observations per group, and vertical lines are SEM.
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by the presence of punctate staining (red, Fig. 3, B and D);
many of these erbB4 clusters appeared to be associated
with regions of SynCAM localization. This apparent as-
sociation was particularly conspicuous in astrocytic pro-
cesses (nonstimulated controls in Fig. 3C vs. NRG1-
treated cultures in Fig. 3D).
The distribution patterns of erbB4 and SynCAM1 after
NRG1 treatment suggested that these proteins become
physically associated after activation of erbB4 receptors.
To test this possibility, we performed coimmunoprecipi-
tation studies. Although SynCAM1-erbB4 interactions
could not be detected in unstimulated astrocytes, coim-
munoprecipitation was observed after a brief (10 min)
stimulation with NRG1 (1 nM) (Fig. 3E), suggesting that
ligand-induced erbB4 activation prompts this receptor to
associate with SynCAM1. Because we and others have
shown that the intracellular domain of
erbB4 (E4ICD) can bind to certain in-
tracellular proteins after it is activated
(4, 25), we used a yeast two-hybrid as-
say to test whether E4ICD is capable of
directly interacting with the intracellu-
lar domain of SynCAM1 (Fig. 3F). The
results showed that WT active E4ICD
interacts with SynCAM1 intracellular
domain, and this interaction is abol-
ished when E4ICD activity is elimi-
nated by a point mutation in tyrosine
751 (K751M) (4).Thus, uponexposure
toNRG1, erbB4 and SynCAM1 asso-






The ability of SynCAM1 to interact
with erbB4 via its intracellular domain
raised thepossibility thatSynCAM1may
use its intracellular domain to elicit sig-
naling events needed for astrocytes to
stimulate GnRH release. To address this
issue, we generated transgenic mice car-
rying a DN SynCAM1 under the tran-
scriptional control of the human GFAP
promoter to target expression of the
transgene to astrocytes. The DN Syn-
CAM1 transgene has intact extracellular
and transmembrane domains but lack
the intracellular protein 4.1, ezrin, ra-
dixin, moesin (FERM) and PDZ [post-
synaptic density protein (PSD95); Dro-
sophila disc large tumor suppressor (DlgA), and zonula
occludens-1 protein (zo-1)] domains, which are replaced
with a sequence encoding EGFP (Fig. 4A). Theoretically, the
DN SynCAM1 protein should adhere to endogenous Syn-
CAM proteins both in cis and in trans via the extracellular
IgG domains but would antagonize signaling events medi-
ated by the intracellular FERM and PDZ domains (11, 18).
Live-cell imaging of BAS 8.1 cells transfected with DN Syn-
CAM1demonstrated that themutant proteinwas appropri-
ately targeted to the plasma membrane (Fig. 4, C and D),
compared with a diffuse, cytoplasmic localization seen in
cells transfected with a cytomegalovirus plasmid eGFP-N1
expression vector (Fig. 4B). The distribution of DN Syn-
CAM1also closely resembles thedistributionof endogenous
SynCAM in hypothalamic astrocytes (12).
FIG. 2. erbB4 receptors are required to maintain SynCAM1 expression in hypothalamic
astrocytes. A, SynCAM1 protein levels are decreased in GFAP-DNerbB4 hypothalamic
astrocytes in culture. Protein extracts were probed with SynCAM1 monoclonal antibody 3E1
and anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) antibodies. B, Densitometric
analysis of blot shown in A. ***, P  0.01 vs. WT astrocytes. C, SynCAM1-isoform 4 mRNA
levels in hypothalamic astrocytes assessed by real-time RT-PCR increases 8 h after stimulating
erbB4 receptors with NRG1 (3 nM). *, P  0.05. D, SynCAM1 protein levels increased in
hypothalamic astrocytes after 16 h of NRG1 treatment. *, P  0.05. E, NRG1 (3 nM, 8 h)
increases SynCAM1 promoter activity in BAS 8.1 astrocyte progenitor cells transiently
expressing human erbB4 (herb4) receptors, and this effect is abolished by overexpression of a
DNerbB4 receptor. ***, P  0.01 vs. all other groups. Numbers in parentheses above bars are
number of independent observations per group, and vertical lines are SEM.
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To determine whether DN SynCAM1 acts in a domi-
nant-negative fashion, we first assessed the ability of the
transgene to interact withWTSynCAM1.Human embry-
onic kidney 293T cells transfectedwith expression vectors
encoding WT SynCAM1 and DN SynCAM1 showed co-
localization of both proteins at the cell membrane (Fig. 5,
A–C), suggesting a physical association between the two
proteins. Coimmunoprecipitation of WT SynCAM1 by
antibodies to the EGFP moiety of DN SynCAM1 verified
this interaction (Fig. 5D). Next, we assessed the ability of
the transgene to disrupt the known interaction of Syn-
CAM1 with the scaffold protein CASK, and the resulting
recruitment of this protein from the cytosol to the cell
membrane (18). Consistent with earlier findings (18), a
CASK-red fluorescent protein (RFP) fusion protein ex-
pressed in 293T cells exhibited a diffuse cytoplasmic dis-
tribution (Fig. 6A, left panels), butwhen the cellswere also
transfected with an expression vector encoding WT Syn-
CAM1, CASK was recruited to the cell membrane (Fig.
6A, left middle panels). As expected, DNSynCAM1alone
did not affect the cytoplasmic distribution of CASK (Fig.
6A, right middle panels); however, it did block CASK re-
cruitment to the cell membrane by WT SynCAM1 (Fig.
6A, right panels). CASK immunoprecipitation resulted in
the coprecipitation of SynCAM1, an interaction that was
prevented by DN SynCAM1 (Fig. 6B). These results indi-
cate that DN SynCAM1 acts as a dominant-negative mol-
FIG. 3. Ligand-dependent activation of erbB4 receptors induces a
direct SynCAM1-erbB4 receptor association in hypothalamic
astrocytes. A–D, Overlaid confocal images of SynCAM (green) and
erbB4 (red) immunoreactivity in WT astrocytes. A and B, Cell bodies of
nonstimulated (A) and NRG1-treated (3 nM, 45 min) WT astrocytes
(B). C and D, Zoomed confocal overlaid images of cell processes from
nonstimulated (C) and NRG1- treated astrocytes (D). E, Stimulation of
erbB4 receptors with NRG1 (1 nM, 10 min) causes interaction
between erbB4 and SynCAM1. Proteins from astrocytes either left
unstimulated (lane 1) or stimulated with NRG1 (lane 2) were
immunoprecipitated (Ipp) with an agarose-coupled erbB4 antibody
and blotted for SynCAM1 (upper right panel). Controls for the
immunoprecipitation include blotting the precipitates with erbB4
antibody (upper left panel) and immunoprecipitation with IgG. Correct
blotting was confirmed by probing nonprecipitated cell lysates (5%
input) for erbB4 and SynCAM1 (lower right and left panels,
respectively). F, Targeted yeast two-hybrid assay using the SynCAM1
intracellular domain as pray and the erbB4 intracellular domain as bait.
WT-erbB4, but not an erbB4 receptor carrying an inactivating point
mutation of the kinase domain (erbB4 KD), interacts with SynCAM1
(expression of LacZ, blue color). PSD95, which interacts with the C-
terminal PDZ binding motif of erbB4 but not with SynCAM1, served as
a positive control. Bars (B–E), 10 m.
FIG. 4. DN SynCAM1 protein is targeted to the plasma membrane of
live astrocytes in culture. A, Schematic illustration of the WT and DN
SynCAM1 proteins. DN SynCAM1 contains the complete extracellular,
transmembrane, and cell membrane targeting domains of WT
SynCAM1 but lacks the intracellular domain. Instead this domain is
replaced by a sequence encoding EGFP. B, Live cell image of an
immortalized BAS8.1 cultured astrocyte transfected with the positive
control cytomegalovirus plasmid eGFP-N1 expression plasmid. C and D,
Live cell images of BAS8.1 cultured astrocytes transfected with the DN
SynCAM1 expression plasmid. Note that eGFP-N1 is diffusely present
throughout the cytoplasm (B), whereas DN SynCAM1 is targeted to
the cell membrane (C). Also notice the accumulation of DN SynCAM1
protein at points of cell to cell adhesion (D, arrows). Bars (B and C), 20
m; (D), 25 m.
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ecule able to prevent SynCAM1 intracellular domain-me-
diated interactions.
Astrocyte-specific disruption of SynCAM1 function
delays female sexual development and adult
reproductive function
Using theDNSynCAM1construct,wegenerated trans-
genicmice and selected two lines (L27andL45) for further
study.We assessed transgene expression byWestern blots
using antibodies against green fluorescent protein (GFP)
for DN SynCAM1 detection and proteins extracted from
brain (cerebral cortex and hypothalamus) and several pe-
ripheral tissues (heart, lung, liver, spleen, kidney, adrenal,
and ovary). Although no GFP-immunoreactive proteins
were detected in any tissues from WT mice (Fig. 7A), the
cerebral cortex and hypothalamus of both L45 (Fig. 7B)
and L27 (data not shown) transgenic mice showed a pro-
teinof a size similar to that expected for theDNSynCAM1
transgene. No such protein was detected in peripheral tis-
sues, indicating thatDNSynCAM1expression is confined
to the nervous system. At the cellular level, no GFP im-
munohistofluorescence was detected in astrocytes from
WT animals (Fig. 7C), but astrocytes for DN SynCAM1
mice exhibited an abundance of the DN SynCAM1 pro-
tein (Fig. 7D, green color). As previously shown for as-
trocytes identified in the transgenic Brainbowmouse (26),
theGFP immunoreactivematerial was distributed beyond
the area of GFAP staining, likely reflecting the presence of
DN SynCAM1 in astrocytic processes not stained for
GFAP. No DN SynCAM1 was detected in neurons iden-
tified by the presence of the neuronalmarkerHUC/D (Fig.
7, E–G). In fact, DN SynCAM1 astrocytes appear to be in
intimate contactwithneuronal cell bodies, as evidencedby
regions amid the astrocytes that are completely devoid of
DNSynCAM1 labeling (Fig. 7E,arrows), but containneu-
ronal cell bodies (Fig. 7, F and G, red).
Female mice from both L27 and L45 lines displayed a
delay in age at vaginal opening (Fig. 8A) and first estrous
(Fig. 8B) compared with WT littermates. Because both
L27 and L45 show identical patterns of DN SynCAM1
expressionanda similar delay in reproductivematuration,
we used L27mice to assess the animals’ fecundity and L45
mice to evaluate alterations in estrous cyclicity. The DN
SynCAM1 mice had a trend toward a reduced number of
pups in the first litter and an even greater and significant
reduction in litter sizes in the second and subsequent litters
compared withWT dams (Fig. 8C). The estrous cycle was
also disrupted in DN SynCAM1 mice (Fig. 8, D and E).
The mutant animals had a significant decrease in the in-
cidence of proestrous (when the preovulatory surge of go-
nadotropins occurs) and a corresponding increase in the
incidence of estrous (Fig. 8D). Examples of estrous cycles
from two WT and two mutant animals across a 21-d pe-
riod illustrate this alteration in cyclicity (Fig. 8E).
Disrupting SynCAM1 in astrocytes impairs
neuregulin-stimulated release of PGE2 and GnRH
The above-described reproductive deficits are similar
to those previously seen in mice with defective astrocyte
erbB4 function (7). Considering that NRG1 stimulates
GnRH secretion indirectly by eliciting PGE2 release from
astrocytes (7), we investigated the possibility that the abil-
ity of NRG1 to stimulate GnRH release is compromised
in DN SynCAM1 mice. Hypothalamic astrocytes from
WTastrocytes respond toNRG1 (3 nM, 16 h)with PGE2
release, but astrocytes fromDN SynCAM1mice fail to do
so (Fig. 8F). To determine whether this deficiency also
FIG. 5. DN SynCAM1 directly interacts with SynCAM1 in transfected
293T cells. A and B, A single confocal section of 293T cells transfected
with expression plasmids encoding WT SynCAM1 (A, red) and DN
SynCAM1 (B, green) shows that both proteins are localized to the
plasma membrane. C, Merged image suggests that SynCAM1 and DN
SynCAM colocalize at the plasma membrane. D, Coimmunoprecipitation
assay of protein extracts from 293T cells transfected with SynCAM1
and DN SynCAM1 confirm that the proteins are physically associated.
SynCAM1 and DN SynCAM1 interaction was identified in protein
extracts that were immunoprecipitated with EGFP antibodies then
blotted with Pleio SynCAM antibodies (upper membrane). To confirm
the pulldown of DN SynCAM1 in the immunoprecipitation, the
membrane was stripped and reprobed with EGFP antibodies (lower
membrane). Lane 1 was loaded with 100 g of protein extract from
293T cells transfected with SynCAM1 and DN SynCAM1 that was not
immunoprecipitated before Western blot analysis. Lane 3 is a negative
control in which the cell proteins were immunoprecipitated using the
IgG fraction of rabbit serum in lieu of EGFP antibodies. Bars (A–C), 10
m. Cell nuclei in A–C (blue color) are stained with Hoechst nuclear
stain.
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occurs in an in vivo context, median eminence (ME) ex-
plants fromWT andDN SynCAM1mice were exposed to
NRG1 (3 nM, 1 h), and the incubation medium was as-
sayed for GnRH. The ME of DN SynCAM1 mice had a
lower (P0.05)basalGnRHsecretion comparedwith the
WT control. Furthermore, theME fromWTmice, but not
that from DN SynCAM1 mutants, responded to NRG1
with GnRH release (Fig. 8G). Despite this difference, the
DNSynCAM1andWTMEexplants released comparable
levels ofGnRH followingK stimulation (Fig. 8H). These
findings indicate that DN SynCAM1 mice have an im-
paired astrocytic PGE2 response to neuregulins. They also
suggest that this deficit decreases the ability of erbB re-
ceptor activation to stimulate GnRH release from GnRH
nerve terminals.
Discussion
SynCAM1 is a member of the Ig superfamily, a large group
of proteins involved in cell surface recognition (27, 28). In
vertebrates, four SynCAM genes, sharing highly conserved
intracellular and extracellular domains have been described
(11). SynCAM1 is abundant in brain neurons in which it
functionsasasynapticadhesionmolecule thatpromotes syn-
aptic assembly (18) and enhances excitatory synaptic trans-
mission (22, 29). In a companion paper (12), we show that,
consistent with its known neuronal site of expression, Syn-
CAM1 is conspicuous in GnRH neurons, but in addition it
is abundantly expressed in hypothalamic
astrocytes. In thepresent report,weshow
that astrocytic SynCAM1 contributes to
the process by which astroglial cells reg-
ulate female reproductive capacity. Syn-
CAM1 associates with erbB4 receptors
via its intracellular domain. Interfering
with this association compromises the
ability of hypothalamic astrocytes to re-
spond to erbB4 receptor activation with
PGE2 release and to elicit GnRH release
from the ME of the hypothalamus. The
physiological importance of these Syn-
CAM1 intracellular actions is under-
scored by the distinct reproductive phe-
notype of delayed puberty, disrupted
estrous cyclicity, and reduced fecundity
observed in transgenic mice that have a
disruption in endogenous astrocytic Syn-
CAM1 function.
Loss of SynCAM1 function in astro-
cytes delayed, but did not prevent pu-
berty. This outcome is similar to the re-
sults of previous studies dealing with
molecules that are involved in the control of puberty, but
do not play a central role in the process. For instance,mice
carrying a dominant-negative form of erbB4 targeted to
astrocytes have a delayed first ovulation, but exhibit nor-
mal adult reproductive capacity (7). Additional examples
are mice carrying a point mutation of the erbB1 receptor
(30, 31) and mice lacking the Janus-activated kinase 2 in
GnRH neurons (32) or lacking the homeodomain protein
Six6 also in GnRH neurons (33). The most tenable expla-
nation for the absence of complete infertility resulting
from these deficiencies is the existence of redundant and
compensatory circuits that become operative when one
system fails to perform. In the present situation, the com-
pensatory activation of additional adhesive molecules
with signaling capabilities in the astrocyte-GnRH neuron
interface, such as the neuronal contactin/glial receptor-
like protein tyrosine phosphatase- system (34), may con-
tribute to explaining the delayed puberty and the partial
loss of fertility observed in DN SynCAM1 mice.
SynCAM1 was earlier proposed to be a member of a
regulatory gene network that operates in the hypothala-
mus to control female reproductive competence (35, 36).
This notion was initially supported by the observation of
increased SynCAM1 mRNA expression in the hypothal-
amus of peripubertal monkeys as compared with juvenile
animals (35). The finding that SynCAM1 mediates astro-
cyte-to-astrocyte and astrocyte-GnRH neuron communi-
cation (12), demonstrates that SynCAM1 is indeed an in-
A B
FIG. 6. DN SynCAM1 inhibits SynCAM1 function by preventing SynCAM1 association to, and
the cellular redistribution of, the scaffold, actin-binding protein CASK. A, left panels, Human
embryonic kidney 293T cells transfected with a CASK-RFP expression plasmid show a cytoplasmic
CASK localization (red). Left middle panels, Cotransfection of CASK-RFP with WT SynCAM1
results in CASK recruitment to the plasma membrane were SynCAM1 is localized (purple). Right
middle panels, Cotransfection of DN SynCAM1 with CASK-RFP does not affect the cytoplasmic
localization of the CASK protein (red), despite the presence of DN SynCAM1 (green) at the plasma
membrane. Right panel, DN SynCAM1 prevents the SynCAM1-dependent recruitment of CASK-
RFP to the plasma membrane. B, DN SynCAM1 prevents the association of WT SynCAM1 to
CASK-RFP as assessed by coimmunoprecipitation assay of protein extracts from 293T cells
transfected with CASK-RFP, WT SynCAM1, and DN SynCAM1. The proteins were
immunoprecipitated with CASK antibodies and blotted with SynCAM1 monoclonal antibodies. To
confirm CASK pulldown, the membrane was reprobed with CASK antibodies (lower panel in B).
Bars, 10 m. Cell nuclei (blue) are stained with Hoechst.
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tegral component of neuroendocrine reproductive func-
tion. In the present study, we show that the abundance of
SynCAM1 in WT astrocytes is maintained through sig-
naling events initiated by erbB4 and that SynCAM1 ex-
pression is depressed in hypothalamic astrocytes from
GFAP-DNerbB4 mice. Binding of NRG1 to erbB4 re-
ceptors leads, to enhanced SynCAM1 gene expression by
directly transactivating the SynCAM1 promoter. Al-
though NRGs are recognized by both erbB3 and erbB4
receptors (2), the latter appear to be the only type of erbB
receptor involved in regulating astroglial SynCAM1 ex-
pression or function under in vivo conditions because nei-
ther hypothalamic nor cerebrocortical astrocytes express
erbB3 receptors (5).
It has been recognized for some time
that adhesion molecules, such as E-cad-
herin, carcinoembryionicantigen-related
cell adhesion molecule 1, and neural cell
adhesionmolecule, canmodify the effect
ofgrowthfactors, suchasbasic fibroblast
growth factor and epidermal growth fac-
tor, on cell function (37–40). However,
theconverse, i.e. theabilityofgrowthfac-
tor receptor activation to influence the
function of adhesion molecules, has not
been examined. Our results provide evi-
dence for this concept. Under basal con-
ditions, erbB4 and SynCAM1 do not
appear tobeassociated, but this indepen-
dence terminates rapidly after the recep-
tor is exposed to NRG1. The present
results also demonstrate that activated
erbB4 receptors and SynCAM1 interact
via their intracellular domains. This is in
contrast to the behavior of neural cell ad-
hesion molecule, which engages basic fi-
broblast growth factor receptors via its
extracellular domain (41). How the in-
tracellular SynCAM1 sequences associ-
ate with activated erbB4 receptors re-
mains to be defined.
Likemany other adhesionmolecules
of the immunoglobulin superfamily
(28), SynCAM1 is capable of signal
transduction. It is endowed with an in-
tracellular domain containing both a
FERM binding motif and a C-terminus
sequence recognized by proteins con-
taining PDZ domains type II (11, 42).
Binding of membrane associated pro-
teins (such as protein 4.1, CASK, and
syntenin) to the FERM- and PDZ-do-
main binding sequences, link Syn-
CAM1 to signaling events resulting in the structural reor-
ganization of the cytoskeleton (42, 43). Our SEM studies
(12) indicate that the initial, adhesive cell response to Syn-
CAM1 involves cytoskeletal reorganization.We observed
that GnRH neuronal processes, formed within minutes of
presenting SynCAM1-Fc coatedbeads to the cells, trap the
beads via SynCAM1-SynCAM1 homophilic interactions.
Our results do not identify the cellular mechanisms un-
derlying the ability of DN SynCAM1 to disrupt astrocytic
SynCAM1 intracellular function. Several possibilities can
be considered based on known SynCAM functions. For
instance, SynCAM1hasbeen shownto selectively enhance
excitatory neurotransmission (29) and work in concert
FIG. 7. DN SynCAM1 is selectively expressed in astrocytes within the adult female
hypothalamus. A, DN SynCAM1 protein, detected with GFP antibodies, is absent in WT
tissues. B, DN SynCAM1 protein expression is confined to the central nervous system in
transgenic mice. Ctx, Cerebral cortex; Hypo, hypothalamus. C–G, DN SynCAM1
immunoreactivity is confined to astrocytes in the transgenic mouse brain. C, Merged confocal
projection images showing the absence of DN SynCAM1 immunostaining (GFP antibodies,
green) in WT hypothalamic astrocytes identified with antibodies to GFAP (red). D, DN
SynCAM1 is abundant in hypothalamic astrocytes from a DN SynCAM1 animal. E–G, DN
SynCAM1 is not expressed in neurons. E, Single confocal section showing DN SynCAM1
immunoreactivity (green) associated with cellular structures surrounding immunonegative cells
(identified by Hoechst staining of cell nuclei). F, Immunostaining of neurons using HUC/D
antibodies (red). G, Merged image of single confocal sections showing that HUC/D
immunoreactive cells are devoid of DN SynCAM1 protein. Bars (C and D), 20 m; (E–G), 40
m. Cell nuclei (blue) are stained with Hoechst.
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with glutamatergic receptors to generate functional ex-
citatory synaptic contacts (18, 29). One mechanism by
which SynCAM1 regulates excitatory neurotransmis-
sion is through the recruitment of N-methyl-D-aspartate
or 2-amino-3-hydroxy-5-methyl-4-isoxazol propionic acid
receptors via the intracellular FERM binding domain of
SynCAM1 (44). Hypothalamic astrocytes express both
metabotropic glutamate and2-amino-3-hydroxy-5-meth-
yl-4-isoxazol propionic acid receptors, which upon acti-
vation initiate a signaling cascade that leads to erbB re-
ceptor activation and glia-to-neuron signaling events
required for normal reproductive devel-
opment (45,46).Therefore, it is tempting
to speculate that astroglial SynCAM1
may act as an adhesion/signaling mole-
cule able to organize excitatory neuron-
to-glia signaling domains in hypotha-
lamic astrocytes.
Complementing this view are our im-
munohistofluorescence results showing
that SynCAM molecules cluster in both
astrocytes and neurons as a consequence
of erbB4 receptor activation. Such clus-
tering suggests the formationofhot spots
of cell adhesion and signaling domains.
SynCAM1 interactions with down-
stream effectors may contribute to both
cytoskeletal reorganization and receptor
distribution. One potential downstream
effector may be CASK because homo-
philic SynCAM1 interactions recruit
CASK to the cellmembrane (18), andwe
show here that overexpression of DN
SynCAM1 abolishes this redistribution.
CASK plays a role in both actin reor-
ganization and receptor distribution.
Through interactions with syndecan-4
andprotein4.1,CASK is coupled toboth
the Rho signaling pathway, involved in
mediating reorganizationof thecytoskel-
eton (47) and the actin cytoskeleton (48,
49). CASK has also been shown to sort
N-methyl-D-aspartate receptors (50) and
serve as binding partner to glutamate re-
ceptor interacting protein (51). In Cae-
norhabditis elegans, Lin2, a CASK or-
tholog, is associated with epidermal
growth factor receptor targeting (52). It
remains to be determined whether simi-
lar interactions also occur in astrocytes.
CASK has also been shown to inter-
act with the N and P/Q type of voltage-
gated calcium channels in neurons (53,
54). If similar interactions occurred in astrocytes, Syn-
CAM1may not only regulate astroglial plasticity but may
also be involved in facilitating two well-established com-
ponents of astrocyte physiology: calcium influx and re-
lease of excitatory neurotransmitters. The impact of these
alterations at the whole-animal level is anticipated to be
noticeable, a premise supported by the distinct alterations
in reproductive function we observed in DN SynCAM1
transgenicmice,which appear to be evenmore severe than
those seen in DNerbB4 animals (7). DN SynCAM1 mice
FIG. 8. Transgenic targeting of DN SynCAM1 to astrocytes disrupts reproductive development
and adult reproductive function in female mice. Panels A–E, Female DN SynCAM1 transgenic mice
have deficits in reproductive development and mature reproductive function capacity. Panel A,
Delayed vaginal opening. Panel B, Delay in the age at first estrus. Panel C, Reduced female
fecundity assessed by the number of pups per litter delivered by each dam. Panel D, Irregular
estrous cycle. Panel E, Examples of estrous cycles tracked for 21 d in two WT (upper panels) and
two DN SynCAM1 (lower panels) mice. Panels F–H, DN SynCAM1 mice have diminished astrocyte
and GnRH neuron responsiveness to NRG stimulation.Panel F, Cultured WT hypothalamic
astrocytes, but not astrocytes from DN SynCAM1 mice, respond to NRG1 (3 nM, 16 h)
stimulation with increased PGE2 secretion. C, Control, basal PGE2 levels before exposure to
NRG1. Panel G, ME explants from DN SynCAM1mice have lower basal GnRH and fail to release
GnRH in response to NRG1 (3 nM, 2 h). Panel H, ME explants fromWT and DN SynCAM1mice
release comparable levels of GnRH after K stimulation.Numbers in parentheses are number of
animals or cultures per group. Bars represent means and vertical lines are the mean SEM. *, P 0.05
and **, P 0.02 vs.WT controls; a, P 0.02 and b, P 0.05 vs. basal GnRH levels inWT controls.
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exhibited not only delayed puberty (assessed by the age at
vaginal opening and first estrus) but also a disruption of
reproductive cyclicity in addition to reduced fecundity (ev-
idenced by the smaller size of litters born to the mutant
mice in comparison with WT controls).
In summary, thepresent studyunveils aphysiological role
forSynCAM1-mediated intracellularsignaling intheprocess
by which astrocytes of the neuroendocrine brain control fe-
male sexual development andmature reproductive function.
Our results demonstrate a functional connection between
glial erbB4 receptors and SynCAM1. We show that ligand-
dependent erbB4 receptor activation results in physical as-
sociation of the receptor to SynCAM1 via their intracellular
domains. In addition, SynCAM1 synthesis is increased. Dis-
ruption of astrocytic SynCAM1 signaling via a dominant
negativeSynCAM1formdisrupts theabilityofneuregulin to
stimulatePGE2 formation inastrocytesand to releaseGnRH
from the hypothalamus, implicating SynCAM1 as a media-
tor of erbB4 activation in hypothalamic astrocytes. The con-
sequences of this interaction are evidenced by the finding
that mice with disrupted astrocytic SynCAM1 signaling
have delayed puberty and reduced reproductive capacity
in adulthood. Our findings raise the possibility of similar
erbB4 receptor-SynCAM1 interactions mediating glia-to-
neuron communication in brain regions other than the
hypothalamus.
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